WO2000029448A3 - Human proteins having hydrophobic domains and dnas encoding these proteins - Google Patents

Human proteins having hydrophobic domains and dnas encoding these proteins Download PDF

Info

Publication number
WO2000029448A3
WO2000029448A3 PCT/JP1999/006412 JP9906412W WO0029448A3 WO 2000029448 A3 WO2000029448 A3 WO 2000029448A3 JP 9906412 W JP9906412 W JP 9906412W WO 0029448 A3 WO0029448 A3 WO 0029448A3
Authority
WO
WIPO (PCT)
Prior art keywords
proteins
hydrophobic domains
dnas encoding
dnas
human
Prior art date
Application number
PCT/JP1999/006412
Other languages
French (fr)
Other versions
WO2000029448A2 (en
Inventor
Seishi Kato
Tomoko Kimura
Original Assignee
Sagami Chem Res
Protegene Inc
Seishi Kato
Tomoko Kimura
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP32625598A external-priority patent/JP2007222001A/en
Application filed by Sagami Chem Res, Protegene Inc, Seishi Kato, Tomoko Kimura filed Critical Sagami Chem Res
Priority to EP99972227A priority Critical patent/EP1161536A1/en
Priority to AU11819/00A priority patent/AU1181900A/en
Publication of WO2000029448A2 publication Critical patent/WO2000029448A2/en
Publication of WO2000029448A3 publication Critical patent/WO2000029448A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants

Abstract

The present invention provides human proteins having hydrophobic domains, DNAs encoding these proteins, and expression vectors for these DNAs as well as eukaryotic cells expressing these DNAs.
PCT/JP1999/006412 1998-11-17 1999-11-17 Human proteins having hydrophobic domains and dnas encoding these proteins WO2000029448A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP99972227A EP1161536A1 (en) 1998-11-17 1999-11-17 Human proteins having hydrophobic domains and dnas encoding these proteins
AU11819/00A AU1181900A (en) 1998-11-17 1999-11-17 Human proteins having hydrophobic domains and dnas encoding these proteins

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
JP32625598A JP2007222001A (en) 1998-11-17 1998-11-17 Human protein having hydrophobic domain and dna encoding the same
JP10/326255 1998-11-17
JP10/364315 1998-12-22
JP36431598 1998-12-22
JP11/69811 1999-03-16
JP6981199 1999-03-16
JP11929999 1999-04-27
JP11/119299 1999-04-27
JP11/138169 1999-05-19
JP13816999 1999-05-19

Publications (2)

Publication Number Publication Date
WO2000029448A2 WO2000029448A2 (en) 2000-05-25
WO2000029448A3 true WO2000029448A3 (en) 2001-12-27

Family

ID=27524206

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP1999/006412 WO2000029448A2 (en) 1998-11-17 1999-11-17 Human proteins having hydrophobic domains and dnas encoding these proteins

Country Status (3)

Country Link
EP (1) EP1161536A1 (en)
AU (1) AU1181900A (en)
WO (1) WO2000029448A2 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19806581A1 (en) * 1998-02-17 1999-10-21 Forschungszentrum Juelich Gmbh Ih ion channel sequences and their use
US6902892B1 (en) 1998-10-19 2005-06-07 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
WO2000050442A2 (en) * 1999-02-26 2000-08-31 Millennium Pharmaceuticals, Inc. Secreted proteins and uses thereof
WO2000063349A1 (en) 1999-04-15 2000-10-26 Icagen, Inc. Human hac3
AU4484400A (en) * 1999-04-23 2000-11-10 University Of Washington Prostate-specific polynucleotides, polypeptides and their methods of use
ES2291198T3 (en) * 1999-07-20 2008-03-01 Genentech, Inc. COMPOSITIONS AND PROCEDURES FOR THE TREATMENT OF IMMUNOLOGICAL TYPE DISEASES.
EP1268506A4 (en) * 1999-07-30 2004-07-28 Millennium Pharm Inc Secreted proteins and uses thereof
KR100543857B1 (en) * 1999-09-01 2006-01-23 제넨테크, 인크. Promotion or Inhibition of Angiogenesis and Cardiovascularization
CN1433482A (en) * 1999-12-09 2003-07-30 三共株式会社 Method of testing remedy or preventive for hyperlipemia
EP1297158A2 (en) * 2000-06-21 2003-04-02 Bayer Aktiengesellschaft Regulation of human eosinophil serine protease 1-like enzyme
US7741029B2 (en) * 2001-03-07 2010-06-22 Andre Schuh Diagnosis and treatment of blood disorders
EP1409676A2 (en) * 2001-03-07 2004-04-21 Andre Schuh Cd109 nucleic acid molecules polypeptides and methods of use
EP1383870A2 (en) * 2001-04-24 2004-01-28 McGILL UNIVERSITY A 150 kda tgf-beta 1 accessory receptor acting as a negative modulator of tgf-beta signaling
CA2498274A1 (en) * 2002-09-16 2004-03-25 Genentech, Inc. Compositions and methods for the diagnosis of immune related diseases using pro7
FR2849055A1 (en) * 2002-12-18 2004-06-25 Exonhit Therapeutics Sa Using inhibitors of protein FKBP65 for treating cancer and other diseases where angiogenesis is involved, also new isoforms of FKBP65, related nucleic acids and diagnostic uses
EP1831370A4 (en) 2004-12-13 2009-08-12 Alethia Biotherapeutics Inc Polynucleotides and polypeptide sequences involved in the process of bone remodeling
JP4965326B2 (en) * 2007-05-01 2012-07-04 独立行政法人科学技術振興機構 A novel family of genes that promote the secretion of bioactive proteins

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998021328A2 (en) * 1996-11-13 1998-05-22 Sagami Chemical Research Center Human proteins having transmembrane domains and dnas encoding these proteins

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998021328A2 (en) * 1996-11-13 1998-05-22 Sagami Chemical Research Center Human proteins having transmembrane domains and dnas encoding these proteins

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
BUCHER ET AL: "A flexible motif search technique based on generalized profiles", COMPUTERS AND CHEMISTRY,GB,PERGAMON PRESS, OXFORD, vol. 20, no. 1, 1996, pages 3 - 23, XP002107535, ISSN: 0097-8485 *
D'ANDREA ET AL: "Molecular Cloning of NKB1. A Natural Killer Cell Receptor for HLA-B Allotypes", JOURNAL OF IMMUNOLOGY,US,THE WILLIAMS AND WILKINS CO. BALTIMORE, vol. 155, no. 5, 1 September 1995 (1995-09-01), pages 2306 - 2310-2310, XP002111500, ISSN: 0022-1767 *
GILLEN C M ET AL: "Molecular cloning and functional expression of the K-Cl cotransporter from rabbit, rat, and human", JOURNAL OF BIOLOGICAL CHEMISTRY,US,AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, vol. 271, no. 27, 5 July 1996 (1996-07-05), pages 16237 - 16244-16244, XP002119528, ISSN: 0021-9258 *
KYTE J ET AL: "A SIMPLE METHOD FOR DISPLAYING THE HYDROPATHIC CHARACTER OF A PROTEIN", JOURNAL OF MOLECULAR BIOLOGY,GB,LONDON, vol. 157, no. 1, 5 May 1982 (1982-05-05), pages 105 - 132, XP000609692, ISSN: 0022-2836 *
SAGARA ET AL.: "Molecular cloning, differential expression, and chromosomal localization of human Frizzled-1, Frizzled-2, and Frizzled-7", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol. 252, no. 1, 9 November 1998 (1998-11-09), pages 117 - 122, XP002132622 *

Also Published As

Publication number Publication date
WO2000029448A2 (en) 2000-05-25
EP1161536A1 (en) 2001-12-12
AU1181900A (en) 2000-06-05

Similar Documents

Publication Publication Date Title
WO2001049728A3 (en) HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS
WO2000005367A3 (en) Human proteins having hydrophobic domains and dnas encoding these proteins
WO2000029448A3 (en) Human proteins having hydrophobic domains and dnas encoding these proteins
AU4189799A (en) Prostate growth-associated membrane proteins
WO2001012662A3 (en) Membrane associated proteins
WO2001012660A3 (en) HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS
WO2001023412A3 (en) Methods of screening for agents which inhibit aggregation of polypeptides
WO2000018922A3 (en) Human carbohydrate-associated proteins
WO2001002563A3 (en) HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS
WO2001049713A3 (en) Stabilizing peptides, polypeptides and antibodies which include them
WO2000026245A3 (en) Human membrane transport proteins
WO2000069884A3 (en) Compositions isolated from skin cells and methods for their use
WO1999049038A3 (en) Human calcium-binding proteins
WO2001049721A3 (en) Bacterial genes and proteins that are essential for cell viability and their uses
WO1999058558A3 (en) Cell signaling proteins
WO2000000594A3 (en) Human transferases
WO2000031263A3 (en) Gtpase associated proteins
WO2001004297A3 (en) Human proteins having hydrophobic domains and dnas encoding these proteins
WO1999009182A3 (en) Rab proteins
AU6063900A (en) Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses
ZA99677B (en) Placental protein 13.
AU4167499A (en) Human proteins having hydrophobic domains and dnas encoding these proteins
WO2001000824A3 (en) HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS
WO2000060082A3 (en) Vesicle associated proteins
WO2000019210A3 (en) Determining the mechanism of beta-amyloid peptide generation

Legal Events

Date Code Title Description
ENP Entry into the national phase

Ref country code: AU

Ref document number: 2000 11819

Kind code of ref document: A

Format of ref document f/p: F

AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 1999972227

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 09856231

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 1999972227

Country of ref document: EP

AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWW Wipo information: withdrawn in national office

Ref document number: 1999972227

Country of ref document: EP